10-Q Filing

INTUITIVE SURGICAL INC CIK: 1035267 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001035267-19-000088`
Period End Date	20190630
Filing Date	20190722
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	isrg-20190630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 73 Cash Flow Statement 68

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	2.50M	shares	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$790.30M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$857.90M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$2.21B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`MarketableSecuritiesCurrent`	$1.93B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$682.30M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$633.40M	USD	Point-in-time
Inventory	`InventoryNet`	$409.00M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryNet`	$512.80M	USD	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$178.80M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	115.20M	shares	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$207.00M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	114.50M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.33B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	115.20M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.07B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	114.50M	shares	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$812.00M	USD	Point-in-time
Property, plant, and equipment, net	`PropertyPlantAndEquipmentNet`	$1.03B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$2.43B	USD	Point-in-time
Long-term investments	`MarketableSecuritiesNoncurrent`	$1.77B	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsNetNoncurrent`	$369.10M	USD	Point-in-time
Deferred tax assets	`DeferredTaxAssetsNetNoncurrent`	$428.60M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$261.00M	USD	Point-in-time
Intangible and other assets, net	`IntangibleAndOtherAssets`	$383.80M	USD	Point-in-time
Goodwill	`Goodwill`	$240.60M	USD	Point-in-time
Goodwill	`Goodwill`	$244.90M	USD	Point-in-time
Total assets	`Assets`	$7.85B	USD	Point-in-time
Total assets	`Assets`	$8.53B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$100.70M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$129.60M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$193.80M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$160.50M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$306.80M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$294.30M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$210.60M	USD	Point-in-time
Other accrued liabilities	`OtherLiabilitiesCurrent`	$231.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$807.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$820.60M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$444.50M	USD	Point-in-time
Other long-term liabilities	`LiabilitiesOtherThanLongtermDebtNoncurrent`	$338.60M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.25B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.16B	USD	Point-in-time
Contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of June 30, 2019, and December 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of June 30, 2019, and December 31, 2018	`PreferredStockValue`	-	USD	Point-in-time
Common stock, 300.0 shares authorized, $0.001 par value, 115.2 shares and 114.5 shares issued and outstanding as of June 30, 2019, and December 31, 2018, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Common stock, 300.0 shares authorized, $0.001 par value, 115.2 shares and 114.5 shares issued and outstanding as of June 30, 2019, and December 31, 2018, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.17B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.43B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.82B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.52B	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-16.40M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-700.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$16.10M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-13.30M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-18.10M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-15.50M	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$7.27B	USD	Point-in-time
Total Intuitive Surgical, Inc. stockholders equity	`StockholdersEquity`	$6.68B	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$14.30M	USD	Point-in-time
Noncontrolling interest in joint venture	`MinorityInterest`	$8.70M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.78B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.28B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.04B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.69B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.87B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.51B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$7.85B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$8.53B	USD	Point-in-time

Income Statement 73 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.10B	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.76B	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$909.30M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.07B	USD	2 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$339.90M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$530.70M	USD	2 Qtrs
Total cost of revenue	`CostOfGoodsAndServicesSold`	$277.00M	USD	1 Quarter
Total cost of revenue	`CostOfGoodsAndServicesSold`	$644.00M	USD	2 Qtrs
Gross profit	`GrossProfit`	$759.00M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.43B	USD	2 Qtrs
Gross profit	`GrossProfit`	$632.30M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.23B	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$279.20M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$552.60M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$481.40M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$259.80M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$264.80M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$190.60M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$95.10M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$120.80M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$817.40M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$400.00M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$672.00M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$354.90M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$359.00M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$277.40M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$554.10M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$611.20M	USD	2 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$32.80M	USD	1 Quarter
Interest and other income, net	`NonoperatingIncomeExpense`	$60.30M	USD	2 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$31.40M	USD	2 Qtrs
Interest and other income, net	`NonoperatingIncomeExpense`	$18.20M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$585.50M	USD	2 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$671.50M	USD	2 Qtrs
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$295.60M	USD	1 Quarter
Income before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$391.80M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$51.10M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$75.40M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$43.60M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$29.30M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$41.00M	USD	1 Quarter
Net income	`ProfitLoss`	$316.40M	USD	1 Quarter
Net income	`ProfitLoss`	$541.90M	USD	2 Qtrs
Net income	`ProfitLoss`	$620.40M	USD	2 Qtrs
Net income	`ProfitLoss`	$254.60M	USD	1 Quarter
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$-700.00K	USD	1 Quarter
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.90M	USD	1 Quarter
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.00M	USD	2 Qtrs
Less: net loss attributable to noncontrolling interest in joint venture	`NetIncomeLossAttributableToNoncontrollingInterest`	$-4.40M	USD	2 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$624.80M	USD	2 Qtrs
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$255.30M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$318.30M	USD	1 Quarter
Net income attributable to Intuitive Surgical, Inc.	`NetIncomeLoss`	$542.90M	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$5.42	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.76	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$4.80	USD	2 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.25	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$5.23	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$4.59	USD	2 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.67	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.15	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	115.40M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	113.50M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	113.20M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	115.20M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	118.50M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.40M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	119.30M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	118.30M	shares	2 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$335.10M	USD	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$542.00M	USD	2 Qtrs
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$257.00M	USD	1 Quarter
Total comprehensive income attributable to Intuitive Surgical, Inc.	`ComprehensiveIncomeNetOfTax`	$654.20M	USD	2 Qtrs

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$316.40M	USD	1 Quarter
Net income	`ProfitLoss`	$541.90M	USD	2 Qtrs
Net income	`ProfitLoss`	$620.40M	USD	2 Qtrs
Net income	`ProfitLoss`	$254.60M	USD	1 Quarter
Depreciation and loss on disposal of property, plant, and equipment	`Depreciation`	$67.80M	USD	2 Qtrs
Depreciation and loss on disposal of property, plant, and equipment	`Depreciation`	$49.80M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$5.70M	USD	2 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$20.50M	USD	2 Qtrs
Loss (gain) on investments, accretion, and amortization, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.60M	USD	2 Qtrs
Loss (gain) on investments, accretion, and amortization, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-4.70M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$52.70M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$48.70M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$157.70M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$120.80M	USD	2 Qtrs
Amortization of contract acquisition asset	`CapitalizedContractCostAmortization`	$5.90M	USD	2 Qtrs
Amortization of contract acquisition asset	`CapitalizedContractCostAmortization`	$5.30M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$17.30M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-48.90M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$133.90M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$178.00M	USD	2 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$89.20M	USD	2 Qtrs
Prepaids and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$102.40M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$14.30M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$21.70M	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-33.30M	USD	2 Qtrs
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-39.60M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$8.70M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$29.80M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-16.10M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-53.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$511.70M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$649.20M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$851.60M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireMarketableSecurities`	$1.82B	USD	2 Qtrs
Proceeds from sales of investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$259.00M	USD	2 Qtrs
Proceeds from sales of investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$61.10M	USD	2 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$724.90M	USD	2 Qtrs
Proceeds from maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$1.42B	USD	2 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$196.90M	USD	2 Qtrs
Purchase of property, plant, and equipment and intellectual property	`PaymentsToAcquireProductiveAssets`	$84.90M	USD	2 Qtrs
Acquisition of businesses, net of cash	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$-1.20M	USD	2 Qtrs
Acquisition of businesses, net of cash	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$38.10M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$9.30M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-531.60M	USD	2 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$119.60M	USD	2 Qtrs
Proceeds from issuance of common stock relating to employee stock plans	`ProceedsFromStockPlans`	$134.90M	USD	2 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$145.00M	USD	2 Qtrs
Taxes paid related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$108.00M	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	2 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$200.00M	USD	2 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	$8.00M	USD	2 Qtrs
Capital contribution from noncontrolling interest	`ProceedsFromMinorityShareholders`	$10.00M	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-5.00M	USD	2 Qtrs
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$34.90M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-220.40M	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-600.00K	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-1.30M	USD	2 Qtrs
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-104.10M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$555.30M	USD	2 Qtrs
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$909.40M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.22B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$805.30M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$663.20M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.22B	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$805.30M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$909.40M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$663.20M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.